PROK — ProKidney Corp. stock price, charts and financials

QT9ProKidney Corp.

ProKidney Corp. (NASDAQ: PROK) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
1.63
+0.07+4.49%
OverviewShort InterestFilings
PROKQT9ProKidney Corp.·NASDAQ
1.63+4.49%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 06, 20264Statement of changes in beneficial ownership
Jun 15, 20264Statement of changes in beneficial ownership
Jun 10, 20263Initial statement of beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 29, 20268-KCurrent report
May 15, 20268-KCurrent report
May 15, 202610-QQuarterly report
Apr 30, 20264Statement of changes in beneficial ownership
Apr 30, 2026SC 13D/ABeneficial ownership statement (active, amended)
Apr 17, 2026DEFA14AAdditional proxy soliciting materials
Apr 17, 2026ARSAnnual report to shareholders
Apr 17, 2026DEF 14ADefinitive proxy statement
Mar 18, 2026S-8Registration of employee benefit securities
Mar 18, 20268-KCurrent report
Mar 18, 202610-KAnnual report
Mar 03, 20264Statement of changes in beneficial ownership
Mar 03, 20264Statement of changes in beneficial ownership
Mar 03, 20264Statement of changes in beneficial ownership
Mar 03, 20264Statement of changes in beneficial ownership
#1 / 25 of 386
Page
▼
/ 16